*Correspondence: Nunzia Balzano [email protected] These authors have contributed equally to this work and share first authorship These authors have contributed equally to this work and share last authorship This article was submitted to Cardiovascular Therapeutics, a section of the journal Frontiers in Cardiovascular Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
They do not have known interactions, but it is always best to consult a healthcare provider before starting any new supplement
Last year, it earned $1.48 billion in revenue, up 69% from $872 million in 2023
Conclusion: PQQ can regulate the pathogenesis of myocardial hypertrophy through the induction of YAP-related anti-ferroptotic activity, highlighting the potential value of PQQ as a novel therapeutic agent capable of slowing or preventing the progression of myocardial hypertrophy and thus delaying the onset of heart failure
Hydration Changes : Weight loss medications can alter fluid balance, potentially affecting joint lubrication
:format(webp))
